Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma
Abstract Non-alcoholic fatty liver disease (NAFLD) is the most common chronic hepatic pathology in Western countries. It encompasses a spectrum of conditions ranging from simple steatosis to more severe and progressive non-alcoholic steatohepatitis (NASH) that can lead to hepatocellular carcinoma (H...
Enregistré dans:
Auteurs principaux: | Sophie Jacques, Arash Arjomand, Hélène Perée, Patrick Collins, Alice Mayer, Arnaud Lavergne, Marie Wéry, Myriam Mni, Alexandre Hego, Virginie Thuillier, Guillaume Becker, Mohamed Ali Bahri, Alain Plenevaux, Emmanuel Di Valentin, Cécile Oury, Michel Moutschen, Philippe Delvenne, Nicolas Paquot, Souad Rahmouni |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/10538d19699b48e291e33a6afd964897 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Statins in Non-alcoholic Steatohepatitis
par: Jose D. Torres-Peña, et autres
Publié: (2021) -
Association between Equol Production Status and Nonalcoholic Steatohepatitis
par: Takemi Akahane, et autres
Publié: (2021) -
Cathepsin D regulates lipid metabolism in murine steatohepatitis
par: Tom Houben, et autres
Publié: (2017) -
New approach to determine the healthy immune variations by combining clustering methods
par: Claire Liefferinckx, et autres
Publié: (2021) -
Lymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathway.
par: Farah Ketroussi, et autres
Publié: (2011)